ANDA 85764, held by Watson Labs. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 85764 (Butabarbital Sodium), held by Watson Labs, was first approved by FDA on Oct 28, 1977, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 28, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butabarbital Sodium15MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters